通过自取决于CST1的稳定,UBE2D2通过抑制铁死来促进胃癌的进展
Yanzhen Yang1, Jingli Xu2, Qianyu Zhao1
1Zhejiang Provincial Research Center for Upper Gastrointestinal Tract Cancer, Zhejiang Cancer Hospital, Hangzhou 310022, China; Department of Hepato-Pancreato-Biliary & Gastric Medical Oncology, Zhejiang Cancer Hospital, Hangzhou 310005, Zhejiang, China; Postgraduate training base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou 310022, Zhejiang, China.
International journal of biological macromolecules
|September 5, 2025
概括
胃癌的进展是由UBE2D2驱动的,它抑制了铁. 针对这种途径诱导细胞死亡,并可能为胃癌腹膜转移提供新的治疗方法.
科学领域:
- 癌症学
- 分子生物学
- 癌症研究
背景情况:
- 胃癌腹膜转移 (GCPM) 是一个严重的临床挑战,治疗选择有限.
- 识别新的分子点对于改善晚期胃癌患者的治疗结果至关重要.
研究的目的:
- 调查基素结合酶E2 D2 (UBE2D2) 作为胃癌 (GC) 的潜在治疗点.
- 阐明UBE2D2影响GC进展和铁亡的分子机制.
主要方法:
- 临床GC样本的分析以评估UBE2D2表达和预后相关性.
- 在体外和体内实验中评估UBE2D2对GC细胞的功能影响.
- 蛋白质查以确定UBE2D2的下游目标.
- 涉及自,氨酸SN (CST1),氨酸过氧酶-4 (GPx4) 和反应性氧物种 (ROS) 的机制研究.
主要成果:
- 在GC组织中,UBE2D2的过度表达与预后不佳有关.
- 抑制UBE2D2抑制了GC细胞的增殖,侵入,迁移和上皮-介质细胞转换 (EMT).
- UBE2D2促进自依赖的CST1降解,导致GPx4不稳定和铁死抑制.
- 通过CST1-GPx4途径诱导了UBE2D2的ROS积累和铁.
结论:
- UBE2D2通过CST1稳定抑制ferroptosis作为GC中的瘤基因.
- 向UBE2D2-CST1-GPx4通路可以诱导ROS介导的铁亡并抑制GC瘤的进展.
- 这一途径代表了胃癌腹膜转移的有希望的治疗策略.
相关概念视频
01:15Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:46Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
01:10Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
01:45Destabilization of Microtubules
2.8K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.8K